In contrast to NICE, the IOM explicitly called its 2015 ME/CFS criteria “diagnostic,” which sounds strange to me given the lack of validation.
A few years ago I talked to a rheumatologist (US), and they said that ME/CFS is a rare disease and that they have barely seen any cases. I suppose that if an American physician runs into such a patient and doesn’t dismiss them as having fibromyalgia, POTS, MCAS, or something else, they will likely check UpToDate, since it’s one of the most widely used clinical references. The ME/CFS chapter is written by Stephanie L. Grach and Stephen J. Gluckman. They write:
“We use the 2015 NAM clinical diagnostic criteria to diagnose ME/CFS.”
“A clinical diagnosis of ME/CFS requires fulfillment of these symptom-based diagnostic criteria and a limited evaluation to exclude underlying organic disease.”
My point is that, whether we like it or not, clinicians tend to take the shortest road. In fact, from what I’ve heard from patients with autoimmune diseases, rheumatologists often rely on criteria too—even though those criteria are classification rather than diagnostic.
Frankly, I’m not even sure that being diagnosed with ME/CFS nowadays is a virtue. In some cases, if it helps someone obtain disability benefits, then yes. In other cases, private doctors are happy to make a diagnosis, but they may exploit patients with concierge fees, ludicrously overpriced appointments, prescriptions for supplements and suggestions for exercise and SSRIs.